(Reuters) - Pfizer Inc agreed to buy two of Baxter International Inc's vaccines and a part of a facility involved in their production for $635 million. The deal will give Pfizer access to Baxter's NeisVac-C, a meningitis vaccine, and FSME-IMMUN, an encephalitis vaccine. Both vaccines are already being sold in the United States. (Reporting by Anand Basu; Editing by Simon Jennings)
via Health News Headlines - Yahoo News http://ift.tt/1tZJRbv
No comments:
Post a Comment